Suitable for Oral Therapy Replacement Cases It is beneficial when oral vitamin supplementation is not possible or effective, such as in critically ill patients, ICU cases, or severe vomiting
This structural selectivity is not a matter of weak binding but rather structural inability to interact with growth hormone receptors
The point of the design is selectivity: because the fragment does not engage the growth-hormone receptor, it does not raise IGF-1 or disturb glucose handling the way full growth hormone can
Tirzepatide alone vs
Around 4.5 in 100 adults fitted that pattern, roughly twice as many as had classic low-B12 deficiency, and it was linked to higher long-term mortality while classic deficiency was not, once other factors were accounted for
PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165